Betel quid without tobacco 1 85, 100E 2012 000542 \200\22388 \200\2231 000107 \200\22330 \200\2232 Bis(chloromethyl)ether; chloromethyl methyl ether (technical-grade) 1 4, Sup 7, 100F 2012 000055 \200\22398 \200\2231 Busulfan 1 4, Sup 7, 100A 2012 000106 \200\22399 \200\2230 1,3 Butadiene 1 97, 100F 2012 007440 \200\22343 \200\2239 Cadmium and cadmium compounds 1 58, 100C 2012 000305 \200\22303 \200\2233 Chlorambucil 1 26, Sup 7, 100A 2012 000494 \200\22303 \200\2231 Chlornaphazine 1 4, Sup 7, 100A 2012 018540 \200\22329 \200\2239 Chromium (VI) compounds 1 49, 100C 2012 Clonorchis sinensis (infection with) 1 61, 100B 2012 Coal, indoor emissions from household combustion of 1 95, 100E 2012 Coal gasi \201 cation 1 92, 100F 2012 008007 \200\22345 \200\2232 Coal-tar distillation 1 92, 100F 2012 065996 \200\22393 \200\2232 Coal-tar pitch 1 35, Sup 7, 100F 2012 Coke production 1 92, 100F 2012 000050 \200\22318 \200\2230 006055 \200\22319 \200\2232 Cyclophosphamide 1 26, Sup 7, 100A 2012 059865 \200\22313 \200\2233 Cyclosporine 1 50, 100A 2012 079217 \200\22360 \200\2230 000056 \200\22353 \200\2231 Diethylstilbestrol 1 21, Sup 7, 100A 2012 Engine exhaust, diesel 1 46, 105 in prep Epstein-Barr virus 1 70, 100B 2012 066733 \200\22321 \200\2239 Erionite 1 42, Sup 7, 100C 2012 49_Smedley_app08.indd 886 1/2/2013 3:32:53 PM AGENTS CLASSIFIED BY THE IARC MONOGRAPHS 887 CAS No. Agent Group Volume Year Estrogen therapy, postmenopausal 1 72, 100A 2012 Estrogen-progestogen menopausal therapy (combined) 1 72, 91, 100A 2012 Estrogen-progestogen oral contraceptives (combined) (NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium an d ovary) 1 72, 91, 100A 2012 000064 \200\22317 \200\2235 Ethanol in alcoholic beverages 1 96, 100E 2012 000075 \200\22321 \200\2238 Ethylene oxide (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other r elevant data) 1 97, 100F 2012 033419 \200\22342 \200\2230 Etoposide (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other releva nt data) 1 76, 100A 2012 033419 \200\22342 \200\2230 015663 \200\22327 \200\2231 011056 \200\22306 \200\2237 Etoposide in combination with cisplatin and bleomycin 1 76, 100A 2012 Fission products, including strontium-90 1 100D 2012 000050 \200\22300 \200\2230 Formaldehyde 1 88, 100F 2012 Haematite mining (underground) 1 1, Sup 7, 100D 2012 Helicobacter pylori (infection with) 1 61, 100B 2012 Hepatitis B virus (chronic infection with) 1 59, 100B 2012 Hepatitis C virus (chronic infection with) 1 59, 100B 2012 Human immunode \201 ciency virus type 1 (infection with) 1 67, 100B 2012 Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 (NB: The HPV type s that have been classi \201 ed as carcinogenic to humans can differ by an order of magnit ude in risk for cervical cancer) 1 64, 90, 100B 2012 49_Smedley_app08.indd 887 1/2/2013 3:32:53 PM APPENDIX 8 Agents Classi \201 ed by the IARC Monographs 888 CAS No. Agent Group Volume Year Human T-cell lymphotropic virus type I 1 67, 100B 2012 Ionizing radiation (all types) 1 100D 2012 Iron and steel founding (occupational exposure during) 1 34, Sup 7, 100F 2012 Isopropyl alcohol manufacture using strong acids 1 Sup 7, 100F 2012 Kaposi sarcoma herpesvirus 1 70, 100B 2012 Leather dust 1 100C 2012 Magenta production 1 57, 99, 100F 2012 000148 \200\22382 \200\2233 Melphalan 1 9, Sup 7, 100A 2012 000298 \200\22381 \200\2237 Methoxsalen 1 24, Sup 7, 100A 2012 (8-methoxypsoralen) plus ultraviolet A radiation 000101 \200\22314 \200\2234 4,4 \200\231 Methylenebis (2-chloroaniline) (MOCA) (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data) 1 57, 99, 100F 2012 Mineral oils, untreated or mildly treated 1 33, Sup 7, 100F 2012 MOPP and other combined chemotherapy including alkylating agents 1 Sup 7, 100A 2012 000091 \200\22359 \200\2238 2 Naphthylamine 1 4, Sup 7, 99, 100F 2012 Neutron radiation (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) 1 75, 100D 2012 Nickel compounds 1 49, 100C 2012 016543 \200\22355 \200\2238 N \200\231-Nitrosonornicotine (NNN) and 4-(N- 1 89, 100E 2012 064091 \200\22391 \200\2234 Nitrosomethylamino)-1- (3-pyridyl)-1-butanone (NNK) (NB: Overall evaluation upgraded to Group 1 based on mechanist ic and other relevant data) Opisthorchis viverrini (infection with) 1 61, 100B 2012 Painter (occupational exposure as a) 1 47, 98, 100F 2012 49_Smedley_app08.indd 888 1/2/2013 3:32:53 PM AGENTS CLASSIFIED BY THE IARC MONOGRAPHS 889 CAS No. Agent Group Volume Year 1 100F 2012 057465 \200\22328 \200\2238 3,4,5,3 \200\231,4 \200\231 Pentachlorobiphenyl (PCB-126) (NB: Overall evaluation upgraded to Group 1 based on mechanis tic and other relevant data) 057117 \200\22331 \200\2234 2,3,4,7,8 Pentachlorodibenzofuran (NB: Overall evaluation upgraded to Group 1 based on mechanistic an d other relevant data) 1 100F 2012 000062 \200\22344 \200\2232 Phenacetin (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) 1 24, Sup 7, 100A 2012 Phenacetin, analgesic mixtures containing 1 Sup 7, 100A 2012 014596 \200\22337 \200\2233 Phosphorus-32, as phosphate 1 78, 100D 2012 007440 \200\22307 \200\2235 Plutonium 1 78, 100D 2012 Radioiodines, including iodine-131 1 78, 100D 2012 Radionuclides, alpha-particle-emitting, internally deposited (NB: Speci \201 c radionuclid es for which there is suf \201 cient evidence in humans are also listed individually as Gr oup 1 agents) 1 78, 100D 2012 Radionuclides, beta-particle-emitting, internally deposited (NB: Speci \201 c radionuclide s for which there is suf \201 cient evidence in humans are also listed individually as Gro up 1 agents) 1 78, 100D 2012 013233 \200\22332 \200\2234 Radium-224 and its decay products 1 78, 100D 2012 013982 \200\22363 \200\2233 Radium-226 and its decay products 1 78, 100D 2012 015262 \200\22320 \200\2231 Radium-228 and its decay products 1 78, 100D 2012 010043 \200\22392 \200\2232 Radon-222 and its decay products 1 43, 78, 100D 2012 Rubber manufacturing industry 1 28, Sup 7, 100F 2012 Salted \201 sh, Chinese-style 1 56, 100E 2012 49_Smedley_app08.indd 889 1/2/2013 3:32:53 PM APPENDIX 8 Agents Classi \201 ed by the IARC Monographs 890 CAS No. Agent Group Volume Year Schistosoma haematobium (infection with) 1 61, 100B 2012 013909 \200\22309 \200\2236 Semustine [1-(2-Chloroethyl)-3- (4-methylcyclohexyl)-1-nitrosou rea, Methyl-CCNU] 1 Sup 7, 100A 2012 068308 \200\22334 \200\2239 Shale oils 1 35, Sup 7, 100F 2012 014808 \200\22360 \200\2237 Silica dust, crystalline, in the form of quartz or cristobalite 1 68, 100C 2012 Solar radiation 1 55, 100D 2012 Soot (as found in occupational exposure of chimney sweeps) 1 35, Sup 7, 100F 2012 000505 \200\22360 \200\2232 Sulfur mustard 1 9, Sup 7, 100F 2012 010540 \200\22329 \200\2231 Tamoxifen (NB: There is also conclusive evidence that tamoxifen reduces the risk of contral ateral breast cancer in breast cancer patients) 1 66, 100A 2012 001746 \200\22301 \200\2236 2,3,7,8 Tetrachlorodibenzo-para-dioxin 1 69, 100F 2012 000052 \200\22324 \200\2234 Thiotepa 1 50, 100A 2012 007440 \200\22329 \200\2231 Thorium-232 and its decay products 1 78, 100D 2012 Tobacco, smokeless 1 89, 100E 2012 Tobacco smoke, second-hand 1 83, 100E 2012 Tobacco smoking 1 83, 100E 2012 000095 \200\22353 \200\2234 ortho-Toluidine 1 77, 99, 100F 2012 000299 \200\22375 \200\2232 Treosulfan 1 26, Sup 7, 100A 2012 000079 \200\22301 \200\2236 Trichloroethylene 1 63, 106 in prep Ultraviolet radiation (wavelengths 100 \200\223400 nm, encompassing UVA, UVB, and UVC) 1 100D 2012 Ultraviolet-emitting tanning devices 1 100D 2012 000075 \200\22301 \200\2234 Vinyl chloride 1 97, 100F 2012 Wood dust 1 62, 100C 2012 X- and Gamma-Radiation 1 75, 100D 2012 M http://monographs.iarc.fr/ENG/Classi \201 cation/index.php 49_Smedley_app08.indd 890 1/2/2013 3:32:54 PM 891 Index A 1% rule, public transportation active noise reduction (ANR) hearing protectors 659 acute toxic effects, de \201 nition 67 4 airborne pollutants, sampling and analysis 48 , 49 alcohol abuse 378 \200\22380 epidemiology 468 \201 tness for work 468 \200\2239 legislati on 379 substance abuse aircraft 485 A weighting, sound levels 4 Ability Net 410 absence see sickness addictions 565 additive effects 616 adrenaline, in absence anaphylaxis 814 policies 378 \200\22380 alcohol addiction 565 alcohol screening 758 \200\2239 alcohol testi ng 469 aldehydes, sampling and absorbed dose, ionizing adulteration of foods 723 adverse reactions, reporting 814 aerosol types 45 aetiological fr action (attributable proportion) 687 age discrimination 572 ageing, and \201 tness for wo rk 452 \200\2233 radiation 17 absorption of substances 674 abuse, violence management analysis 50 policies 388 \200\2239 alkali burns, eye 793 allergens, classi \201 cation 198 allergic contact dermatitis access to health records 579 Access to Medical Reports (ACD) 242 prognosis 245 see also dermatitis Act 1988 580 \200\2231 Access to work scheme Agent Orange (AtW) 410 accident books 537 accident data 736 accidents syndrome 332 \200\2233 allergic contact aggression 136 \200\2237 agomelatine 458 agricultural workers urticaria 246 allergic rhinitis 859 \200\22361 allergies causes 732 Control of Major Accident Hazards Regulations 1999 590 \200\2231 good occupational hygiene to animal products 112 conjunctivitis 280 to latex 202 \200\2233 to organic dusts and practices 113 organic dust toxic syndrome (ODTS) 205 costs 734 \200\2235 de \201 nition 534 , 732 investigation and mists 114 prescribed diseases 847 , see also asthma; rhinitis 848 , 849 , 850 allodynia 296 alpha particles 16 aluminum 62 management 732 \200\2233 radiation exposure 543 reporting 735 Reporting of Injuries, AIDS (acquired immune de \201 ciency syndrome) 156 bauxite worker \200\231s lung 216 Alzheimer \200\231s disease 456 \200\2237 4-aminobiphenyl exposure, prescribed diseases 853 amitriptyline, in PTSD 314 ammonia, respirator see also HIV Disease and Dangerous Occurrences Regulations 1995 534 \200\2235 aims of occupational medicine 340 air conditioning humidi \201 er fever 208 and legionnaires \200\231 disease 168 and sick building risk during long working \201 lters 657 hours 142 risk during night shifts 140 amplitude-sensitive hearing protectors 658 anemia 326 , 851 syndrome 334 acclimatization to heat 35 accuracy of assays 606 acetic anhydride 77 acetone 76 arsine 97 bone marrow air pollution indoor 716 \200\22317 outdoor 714 \200\22315 aplasia 324 \200\2235 \201 tness for air passenger air travel biological monitoring 625 travel 483 haemolysis 329 lead exposure 70 jet lag 144 \200\2235 medical emergencies 483 physics and acid anhydrides (cyclic anhydrides) 77 acne 249 , 878 acoustic neuroma 433 acro-osteolysis 251 acrylamide 78 analgesia 754 \200\2235 analysis physiology 480 \200\2231 and speci \201 c medical conditions 482 \200\2233 see also cabin crew; pilots errors and corrections 607 quality assurance 607 selection of method 606 prescribed diseases 852 airborne concentration, acrylonitrile 79 active monitoring 604 units 679 50_Smedley_Index.indd 891 1/2/2013 3:36:24 PM INDEX 892 baritosis 216 , 226 barotrauma 842 basal cell carcinoma 247 basic surveys 608 basophilic st ippling, red welding fume anaphylaxis 814 \200\22315 , 850 exposure 60 asthma 198 \200\223200 , 861 , latex allergy 202 angiography/angioplasty, expected time off work 409 862 \200\2233 , 873 cobalt exposure 67 cyclic anhydrides cells, lead exposure 70 animal workers 850 bauxite 62 bauxite worker \200\231s lung 216 beat conditions 262 , 867 Beck Depression Inve ntory 751 becquerel (Bq) 16 before and after (acid anhydrides) exposure 77 biological hazards 112 \200\22313 prescribed diseases 848 , \202 our dust exposure 51 formaldehyde 849 RIDDOR reportable exposure 84 diseases 868 , 869 , 873 grain dust exposure 52 latex allergy 202 organic dusts and mists 114 respirator use 500 ros in exposure 59 serial peak \202 ow ankylostomiasis 848 antagonistic effects 616 anthrax 112 , 113 , 176 , 830 , comparisons 704 behavioral types, and heart 848 , 868 disease risk 238 antidepressants 458 anti-retroviral therapy bene \201 cence 360 benzene 80 (ART) 156 testing 762 \200\2233 post-exposure HIV bone marrow aplasia 324 hematological sulfur dioxide prophylaxis 822 \200\2233 exposure 102 anxiety 238 anxiety assessment tools 750 \200\2231 malignancies 330 health surveillance 325 legislation 325 prescribed diseases 852 welding fume exposure 60 wood dust exposure 53 appendectomy, expected time off work 409 asthmagens, benzidine, prescribed diseases 853 benzylpenicillin, in meningococcal infection 164 berylli osis 216 , 852 beryllium 64 beta particles 16 beta-naphthylamine respiratory health surveillance 428 \200\2239 Approved Codes of Practice (ACOPs) 514 \200\230arc eye \200\231 280 , 281 archiving records 350 \200\2231 area sample s 604 armed services, \201 tness assessment 486 \200\2237 military pilots 487 \200\2238 r ecruits 486 , 487 aromatic compounds, atopy 198 association with latex allergy 202 dermatitis risk 243 atropine, in organophosphate poisoning 802 exposure, RIDDOR reportable diseases 870 attributable proportion 687 attributable risk 686 audiometry Bhopal incident 715 bias 690 bicipital tendinitis, diagnostic biological monitoring 625 hearing loss arsenic 63 classi \201 cation 430 \200\2231 criteria 257 prescribed diseases 851 , patterns of hearing loss 432 \200\2233 bio-aerosols, role in sick 853 building syndrome 335 RIDDOR reportable diseases 870 audiometry biological effect screening 764 \200\2235 monitoring 624 biological exposure limits 626 water contamination 718 audit 353 \200\2232 arsine 97 , 329 arthroscopy, expected time external 354 , 355 national 355 audit cycle 353 auramine exposure, biological hazards 599 animals and animal off work 409 asbestos \201 bres 55 Control of Asbestos Regulations 2006 540 \200\2231 products 112 \200\22313 prescribed diseases 853 autonomic dysfunction 296 vibration-induced 300 categorization 532 genetically modi \201 ed sampling and analysis 49 organisms 110 \200\22311 human tissue and body autonomy 360 \200\2231 avian chlamydiosis 850 avian in \202 uenza 174 asbestosis 216 , 220 , 857 asbestos-related \202 uids 104 \200\2236 microbial pathogens 108 organic dusts and mists 114 \200\22315 diseases 214 \200\22315 , 859 , 864 , 871 benign pleural B Bacillus anthracis 176 back pain 254 \200\2235 biological monitoring 624 , assessment of dermal exposure 621 disorders 230 laryngeal cancer 234 lung cancer 228 \200\2239 mesothelioma 230 \200\2231 ethical vibration-induced 8 background radiation 16 bagassosis 206 considerations 630 \200\2231 asphyxia interfering factors 628 carbon monoxide 98 50_Smedley_Index.indd 892 1/2/2013 3:36:24 PM INDEX 893 calcium gluconate, in hydro \202 uoric acid exposure 811 \200\22312 hepatitis B; hepatitis C; HIV blue light hazard 12 body \202 uids 104 \200\2236 ionizing radiation 21 optimum sampling times 631 Caldicott guardian, de \201 nition 578 cancer incidence practical exposure routes 105 speci \201 c guidance 106 body mass index (BMI) calculator 882 considerations 630 samples and analytes 625 statistics 692 \200\2233 biological monitoring guidance values (BMGVs) 626 , 627 biological tolerance values cancers bladder 274 \200\2235 brain 288 \200\2239 gastrointestinal 270 \200\2231 hepatic boiler scaling, prescribed diseases 858 bone damage, vinyl chloride 96 (BATS) 626 biological weapons 830 \200\2231 biomarkers angiosarcoma 264 \200\2235 bone marrow aplasia 324 \200\2235 Borrelia burgdorferi 186 \200\2237 bovine spongiform ence phalopathy (BSE) 113 , 160 \200\2231 , 162 laryngeal 234 lung cancer 228 \200\2239 mesothelioma 230 \200\2231 nasal 232 skin 247 see a lso under speci \201 c cancer types canopies 640 , 641 canteens, legislation 527 Caplan \200\231s syndrome 219 captan benzene 80 beryllium 64 lead 70 biotransformation 674 biphenyl-4-ylamine, bovine tuberculosis 113 Bradford score 403 brain cancer 288 \200\2239 breakthrough time, prescribed diseases 853 bipyridylium pesticides 90 bird fancier \200\231s lung 206 birth defects 320 \200\2231 bis (chloromethyl) ether protective gloves 662 breast-feeding 524 , 527 , 571 breathing apparatus 654 protection val ues 656 types 655 exposure prescribed diseases 865 RIDDOR reportable diseases 869 bitumen exposure, risk phrases 90 workplace exposure limits 92 bromomethane exposure, see also pesticides prescribed diseases 852 prescribed diseases 853 capture velocity, bronchial provocation challenge tests 199 bronchiolitis obliterans 855 bronchitis, chronic 866 brucellosis 112 , 113 , 184 , de \201 nition 647 Black Creek Village, soil pollution 720 \200\2231 bladder cancer 274 \200\2235 , capture zone, hoods 647 carbolic acid see phenol carbon disulphide 81 , 238 parkinsonism 29 2 , 293 prescribed diseases 852 psychosis 306 carbon electrode manufacture 853 , 870 2,2 \200\231-dichloro- 849 , 868 bulk samples 604 Burkholderia mallei 178 bursitis 262 , 842 , 867 business ethics 364 butan-2-one, BMGV 627 butanedione exposure, 4,4-methylene dianiline 83 rubber process dust/ fume 58 blinding (experimental prescribed diseases 858 RIDDOR reportable diseases 871 carbon monoxide 98 studies) 705 blister agents 829 blood-borne viruses (BBV) 150 \200\2231 prescribed diseases 855 2-butoxyethanol, BMGV 627 BMGV 627 poisoning 794 \200\2235 n-butyl methyl ketone \201 tness for exposure prone procedures 496 guidance for health care carbon tetrachloride 266 prescribed diseases 854 renal toxicity 272 exposure, prescribed diseases 855 workers 106 hepatitis B 152 \200\2233 hepatitis C 154 \200\2235 human immunode \201 ciency byssinosis 50 , 204 , 859 , 871 carboxyhaemoglobin 795 carcinogenesis 675 carcinogens 887 \200\22392 acrylamide 78 acryloni trile 79 air pollution 714 arsenic 63 cadmium 65 2,2 \200\231-dichloro-4, C C weighting, sound levels 4 cabin crew, \201 tness for virus 156 \200\2237 human material associated with transmission 105 work 485 cadmium 65 occupations at risk 105 routes of exposure 105 transmission from healthcare workers 494 vir al haemorrhagic fevers 158 biological effect monitoring 624 4-methylene dianiline 83 diesel engine exhaust biological monitoring 625 health surveillance 272 prescribed diseases 852 rice contaminatio n 722 calcium chromate exposure, prescribed diseases 865 emissions (DEEE) 57 exposure control 634 formaldehyde 84 see also exposure prone procedures (EPPs); 50_Smedley_Index.indd 893 1/2/2013 3:36:24 PM INDEX 894 chromic acid mist, sampling (COSHH) regulations 2002 532 \200\2233 carcinogens (Cont \200\231d ) and analysis 49 machine-made mineral \201 bre (MMMF) 56 metal working \202 uids 61 nickel 73 rubber pro cess dust/ chromium and chromium eye injuries 278 \200\2239 , 280 management of chemical exposures to the eye 793 compounds 66 biological monitoring 625 chromium VI, BMGV 627 prescribed diseases 855 , REACH framework fume 58 861 554 \200\2235 tetrachloroethylene 95 vinyl chloride 96 wood dust 53 cardiotoxicity 852 cardiovascular dis ease, RIDDOR reportable diseases 869 , 870 chemical mixtures 616 chemical protection, glove chronic beryllium disease materials 663 (CBD) 64 chemical safety assessments chronic bronchitis, coal dust (CSA) 554 , 555 chemical weapons 829 chest X-ray \201 tness for air passenger travel 482 exposure 49 chronic fatigue syndrome cardiovascular effects in asbestosis 220 in berylliosis 224 in mesothelioma 231 in pneumoconioses 217 (CFS) 460 \200\2231 chronic obstructive carbon disulphide 81 carbon monoxide 98 pesticides 90 pulmonary disease (COPD) 212 \200\22313 , 866 carpal tunnel kaolin coal miners 218 chronic pain 754 \200\2235 chronic toxic effects, de \201 nition 674 syndrome 294 \200\2235 , 846 , 867 pneumoconiosis 225 in silicosis 222 diagnostic criteria 257 medical management 256 prognosis 256 \200\2237 vibration-induced 10 , 300 child employment 572 cigarette smoke, role in sick building syndrome 334 de \201 nitions 523 health and safety cipro \202 oxacin legislation 521 , 522 carpet \201 tters, prescribed in anthrax 177 meningococcal working time diseases 847 regulations 574 , 575 childhood leukemia, and case-control studies 702 \200\2233 case de \201 nition 684 research paper prophylaxis 164 circulatory disorders, vinyl ELF 24 chloride 96 children, \201 tness to work assessment 782 cirrhosis, hepatic 266 \200\2237 , with 498 \200\2239 case managers 343 case mix 690 cataract surgery, expected time off work 409 cataracts 282 , 842 , 867 Center for Emergency Preparedness and Response, HPA 712 852 china clay mining, kaolin pneumoconiosis 225 citalopram 458 City University Test, color china manufacture vision 767 prescribed diseases 857 RIDDOR reportable diseases 871 chlamydia infections 112 , civil compensation 561 civil law 558 \200\2239 Classi \201 cation, Labeling and Packaging of Substances and Mixtures (CLP) regulations 42 , 43 clinical governance 355 Clinician Admi nistered 188 \200\2239 , 850 , 868 Center for infections, Chlamydia psittaci 320 HPA 712 chloracne 249 chlorinated naphthalenes exposure, prescribed diseases 852 Center for Radiation, Chemical and Environmental Hazards, HPA 712 \200\22313 Assessment Scale for PTSD (CAPS) 313 Clostridium tetani 170 clusters 4-chloro-2-methylaniline cerebellar degeneration 851 chain of custody, biological exposure 275 prescribed diseases 853 samples 759 chance variation 690 Chemical (Hazards chloroform 82 causes 715 investigation 696 \200\2237 CNS toxicity 851 , 852 coal dust 49 prescribed diseases 855 chlorpheniramine, in anaphylaxis 814 Information and Packaging for Supply) Regulations (CHIP) 42 , 677 chlorpyriphos prescribed diseases 866 risk phrases 90 workplace exposure coal miners classi \201 cation of prescribed diseases 847 , chemicals 43 chemical hazards 599 aerosol types 45 classi \201 cation and labeling 42 limits 92 865 , 866 see also pesticides RIDDOR reportable diseases 870 , 871 choking agents 829 cholecystectomy, expected time off work 409 \200\230Choosing Health \200\231 White Coal Mines (Control of Inhalable Dust) Regulations (CIDR) 2007 49 classi \201 cation glossary 43 Control of Substances Paper 395 Hazardous to Health 50_Smedley_Index.indd 894 1/2/2013 3:36:24 PM INDEX 895 risk assessment 816 , 817 source testing 816 see also needlestick meningococcal coal tar acne 249 coal worker \200\231s infections 165 mercury exposure 307 orf 195 parkinsonism 293 peripheral pneumoconiosis 216 , 218 \200\22319 cobalt 67 injuries control hierarchy 636 \200\2237 control measures 634 \200\2235 biological monitoring 625 neuropathy 297 pneumoconioses 217 Code of Practice on Employment 2011 reasonable adjustments for disability 567 assessment of effectiveness 601 berylliosis 224 coal worker \200\231s Control of Asbestos Regulations 2006 540 \200\2231 pneumoconiosis 219 codes of ethics, occupational hygienists 598 cognitive behavioral Control of Lead at Work silicosis 223 Regulations 2002 538 \200\2239 Control of Major Accident Hazards Regulations (COMAH) 1999 5 90 \200\2231 Control of Noise at Work Regulations 2005 4 \200\223549 Q fever 191 renal toxicity 272 rhinitis 199 scleroderma 251 sinonasal cancer 232 skin cance rs 247 state bene \201 ts 560 Streptococcus suis 182 vibration white \201 nger 301 vitil igo 248 voice disorders 237 compressed air work therapy (CBT) 458 , 752 \200\2233 cognitive impairment 456 \200\2237 cohort studies 700 \200\2231 cold exposure Control of Substances Hazardous to Health (COSHH) regulations 2002 42 , 532 \200\2233 assessment 36 \200\2237 health effects 36 risk control 36 monitoring 600 colophony 59 color vision testing 766 \200\2237 colposcopy, expected time Control of Vibration at Work Regulations 2005 550 \200\2231 controlled waste, de \201 niti on 586 controls, selection 702 convulsions prescribed diseases 842 RIDDOR reportable diseases 867 Work in Compressed Air Regulations 1 996 546 \200\2237 off work 409 communication, in risk management 421 compensation 303 , 560 \200\2231 anthrax 177 asbestos-related diseases 215 in cyanide poisoning 799 in hydrogen sulfide poisoning 801 in organophosphate poisoning 802 compression neuropathies 294 \200\2235 computer systems, security 348 \200\2239 computer viruses 349 con \201 dence intervals 689 con \201 dentiality 340 , 350 \200\2231 , asthma 199 benzene exposure 330 bladder cancer 275 brucellosis 185 bursitis 262 byssinosis 204 carpal tunnel in phenol poisoning 807 copper 68 corneal abrasions 278 \200\2239 corneal dystrophy 852 coronary artery bypass 362 disclosing information syndrome 295 grafts (CABG), expected time off work 409 without consent 363 cataract 282 chlamydiosis 189 civil compensation 561 COPD 213 dermatitis 243 extrinsic alle rgic alveolitis 207 legislation 351 coronary heart con \201 ned spaces working, \201 tness for work 500 confounding factors 690 disease 238 \200\2239 cortical degeneration 851 cotton dust 50 research paper byssinosis 50 , 204 , 859 , assessment 782 conjunctivitis 198 , 280 \200\2231 871 counseling 752 counselors 343 Coxiella burnetii 190 \200\2231 creatinine correction 626 Creutzfeldt \200\223Jakob disease folliculitis and acne 249 glanders 178 hepatic angiosarcoma latex allergy 202 consent 362 \200\2233 for occupational health assessment 839 \200\22340 265 hepatitis B 153 hepatitis C 155 hepatotoxicity 269 hip osteoarthritis 261 human immunode \201 ciency for referral 749 for source testing 816 withholding of 363 consultations, record keeping 74 8 \200\2239 contact urticaria 246 containment levels, (CJD) 160 \200\2231 Crimean/Congo haemorrhagic fever 158 criminal law, differences from civil law 559 Criminal Records Bureau (CRB) checks 498 criti cal incident debrie \201 ng virus (HIV) 157 lead exposure 326 leptospirosis 181 liver \201 brosis 267 lung cancer 228 \200\2239 Lyme disease 187 microbial pathogens 108 \200\2239 contamination incidents (CISD) 314 \200\22315 classi \201 cation 816 cross-sectional surveys 698 50_Smedley_Index.indd 895 1/2/2013 3:36:24 PM INDEX 896 in organophosphate poisoning 802 decompression illness 547 , crude absence rate 402 Cryptosporidium 192 crystalline silica (quartz) 54 cubital tunnel 842 in phenol poisoning 807 2,2 \200\231-dichloro-4,4-methylene dianiline (MbOCA) 83 , 853 deep vein thrombosis, travel-related 383 , 480 dementia 456 \200\2237 dental \202 uorosis 718 depression 458 \200\2239 syndrome 294 customer-driven quality 352 cutaneous anthrax 176 cyanide poisoning 796 \200\2237 BMGV 627 dichloromethane 238 heart disease risk 238 depression assessment BMGV 627 treatment 798 \200\2239 cyanides as chemical weapons 829 cyclic anhydrides (acid anhydrides ) 77 dichromates, prescribed diseases 855 , 861 tools 750 \200\2231 derived no-effect level (DNEL) 554 dicobalt edetate, in cyanide dermal absorption 678 dermal exposure 617 poisoning 798 diesel engine exhaust cyclohexanone, BMGV 627 cyclone respirable sampler 48 conceptual model 618 measurement and uptake estimation 620 \200\2231 emissions (DEEE) 57 diffuse air pollution, health effects 715 diffuse pleural cystoscopy, expected time dermal uptake off work 409 thickening 230 estimation 621 dermatitis 855 , 861 , 872 dilution ventilation 642 \200\2233 direct discrimination 566 direct standardization 685 dis ability D D&C, expected time off acrylonitrile 79 arsenic 63 carbon disulphide 81 causal exposures/ industries 243 classi \201 cation 242 clinical features 242 \200\2233 compensation 243 epidemiology 242 formaldeh yde 84 individual work 409 de \201 nition 564 \200\2235 discrimination 566 \200\2237 employer \200\231s duties 566 \200\2238 occupational health reports 565 daily personal exposure level (L EP,d ) (noise) 4 determination 7 dangerous incidents, Reporting of Injuries, Disease and Dangerous Occurrences Regulations 1995 534 \200\2235 dat a, de \201 nition 578 data back-ups 348 data collection 354 data controller, disability services 410 \200\22311 disciplinary hearings, \201 tness to attend 459 discrimination susceptibility 243 age discrimination 572 Equality Act 2010 562 , latex allergy 202 legislation 243 management 244 \200\2235 metal working \202 uids exposu re 61 prognosis 244 \200\2235 rubber process dust/ 566 \200\2238 sex discrimination 570 \200\2231 de \201 nition 578 data interpretation disease clusters causes 715 investigation 696 \200\2237 display screen equipment biological exposure limits 626 fume 58 biological monitoring wood dust exposure 53 dermatitis screening 426 detailed surveys 608 deterministic effects, assessment 780 \200\2232 Health and Safety (Display Screen Equipment) Regulations 1992 528 \200\2239 guidance values 626 creatinine correction 626 exposure to chemical mixtures 616 time-weighted average concentrations 614 ionizing radiation 17 distribution of substance in development projects, environmental impact assessments (EIAs) 592 \200\2233 the body 674 diving units 626 and air travel 480 \201 tness assessment 476 \200\2237 skin infections 252 data processors, eight principles of good practice 579 Data Protection Act 1998 578 \200 \2239 diabetes mellitus 462 \200\2233 \201 tness for air passenger Diving at Work Regulations travel 482 \201 tness to drive 472 1997 544 \200\2235 \201 rst aid cover 537 diacetyl exposure, data sources, routine health diving contractors, de \201 nition 544 diving operations, de \201 nition 544 prescribed diseases 855 statistics 692 \200\2233 diarrhea data subject, de \201 nition 578 Davidson Trauma Scale acrylonitrile 79 travel-related 383 (DTS) 313 diving projects, diazepam De Quervain \200\231s disease, de \201 nition 544 in cyanide poisoning 799 in hydrogen sulfide poisoning 801 diagnostic criteria 257 documentation see records; deafness 843 \200\2234 reports see also hearing loss 50_Smedley_Index.indd 896 1/2/2013 3:36:24 PM INDEX 897 environmental impact effect modi \201 cation 691 effective dose, ionizing domestic premises, de \201 nition 526 doors, legislation 527 dose equivalent, ionizing assessments (EIAs) 592 \200\2233 radiation 17 environmental EH40 678 elbow disorders 867 medicine, general principles 710 \200\22311 environmental protection radiation 17 dosemeters, ionizing radiation 20 bursitis 262 diagnostic criteria 257 medical management 256 prognosis 256 \200\2237 electri cal safety 740 electromagnetic \201 elds food contamination dose \200\223response data 600 dosimeters (personal sound 722 \200\2233 Health Protection level meters) 6 , 7 doxycycline, leptospirosis prophylaxis 181 Agency 712 \200\22313 indoor air (EMFs) 24 pollution 716 \200\22317 prescribed diseases 842 RIDDOR reportable diseases 867 electronic records 348 \200\2239 ele mental mercury poisoning 804 e-mail, security 349 emergency response vehicles, \201 tness to drive 472 drinking water pollution 718 \200\22319 outdoor air Driver and Vehicle Licensing pollution 714 \200\22315 soil pollution 720 \200\2231 water pollution 718 \200\22319 Agency (DVLA), noti \201 cation of medical conditions 472 , 473 , 474 Environmental Protection Act 1990 586 \200\2237 environmental radiation driving adaptations for disabled drivers 410 detectors 20 and diabetes mellitus 463 and epilepsy 465 , 466 \201 tness to drive 289 , 472 \200\2233 emphysema 852 , 866 personal monitoring devices 20 coal dust exposure 49 nitrogen dioxide 100 rubber process dust/ environmental risk forklift truck management 598 epidemic in \202 uenza 174 epidemiological studies operators 474 \200\2235 LGV/PCV drivers 474 fume 58 employee assistance safety issues 742 \200\2233 whole-body vibration 8 drug misuse see substance program (EAP) 387 601 employees, obtaining consent for OH assessment 839 \200\22340 epidemiological surveys, dermatitis investigation 244 \200\2235 abuse drug screening 758 \200\2239 drum \201 lling, alternative methods 639 Employers \200\231 Liability epidemiology case-control (Compulsory Insurance) Act 1969 561 studies 702 \200\2233 cohort studies 700 \200\2231 cross-sectional surveys 698 Dupuytren \200\231s Employment and Support Allowance (ESA) 400 contracture 300 dusts employment law 558 de \201 nitions and age discrimination 572 Equality Act 2010 562 sex discrimination 570 \200\2231 working time regulations experimental examples 45 organic 114 \200\22315 rubber process dust/ studies 704 \200\2235 interpretation of associations 690 \200\2231 investigation of disease clusters 696 \200\2237 fume 58 1998 574 \200\2235 sampling and analysis 49 see also coal dust; cotton dust; \202 our dust; grain dust; wood dust employment tribunals 558 endogenous eczema 242 endosulfan measures of association 686 \200\2237 dysbaric illness 546 dysbarism 842 risk phrases 90 workplace exposure measures of disease occurrence 684 \200\2235 research planning 694 \200\2235 routine health limits 92 see also pesticides enforcing authorities, de \201 nition 534 E earmuffs 658 earplugs 658 earthenware manufacture prescribed diseases 857 RIDDOR reportab le diseases 871 statistics 692 \200\2233 statistical inference engineering controls 640 \200\2231 ENT conditions, \201 tness for air passenger travel 48 3 688 \200\2239 epilepsy classi \201 cation of seizures 464 epidemiology 464 \201 tness for work 465 \200\2236 \201 tness to work with children 499 enteric zoonoses 192 Environment Agency (EA) 588 \200\2239 Ebola virus 158 eczema see dermatitis educational establishments, provisions for disabled s tudents 411 environmental exposures, health effects 711 environmental health treatment and of \201 cers (EHOs) 512 prognosis 464 \200\2235 50_Smedley_Index.indd 897 1/2/2013 3:36:24 PM INDEX 898 restrictions from work 496 \200\2237 exposure variability 610 external quality expectant mothers see Equality Act 2010 562 pregnancy and age 453 de \201 nition of disability 564 disability provisions 566 \200\2238 and educa tional experimental studies 704 \200\2235 Expert witnesses 364 exposure assessment 418 case-contro l studies 703 cohort studies 700 research paper standards 354 , 355 extraction ventilation devices 640 \200\22334 extremely low-frequency \201 elds (ELFs) 24 establishments 411 and pre-placement assessments 449 interpretation 783 see also environmental ergonomics extrinsic allergic age-related 453 de \201 nition 118 alveolitis 206 \200\2237 , 849 , 872 exposure exposure control 634 \200\2235 ergonomics grain dust exposure 52 control hierarchy 636 \200\2237 general (dilution) assessments 776 eye damage 278 \200\2239 monitoring and analysis techniques 777 ergonomics hazards 599 cataract 282 corneal dystrophy 852 hydro \202 uoric acid exposure 812 ventilation 642 \200\2233 factors affecting performance 644 lifting and handling LEV systems 644 \200\2237 hardware/engineering solutions 640 \200\2231 software/organizatio nal 120 \200\2232 management of chemical overview 118 \200\22319 posture 124 \200\2236 repetitive work 128 \200\2239 exposures 793 phenol exposure 93 , 807 retinal burns 284 \200\2235 methods 638 see also local exhaust ventilation (LEV) systems; personal protective equipment (PPE) ergonomists 343 ERPC (evacuation of eye irritation acetone 76 carbon disulphide 81 copper 68 cyclic anhydrides (acid anhydrides ) 77 formaldehyde 84 glutaraldehyde 85 hydrogen sulfide 99 isocyanates 86 methyl ethyl keto ne 87 styrene 94 sulfur dioxide 102 vanadium 74 retained products of conception), expected time off work 409 erysipeloid 194 erythropoietin, after acute radiation exposure 324 escalators, legislation 527 Escherichia coli 0157 192 ethical guidance 361 ethical principles 360 \200\2231 ethical reviews, exposure data, use in litigation 601 exposure evaluation 598 exposure limit values (ELVs), noise 4 \200\2235 exposure monitoring 600 dermal exposure 617 \200\22318 measurement and uptake estimation 620 \200\2231 epidemiological investigations 695 eye protection 666 \200\2237 ethics information to be collected 611 biological monitoring 630 \200\2231 F face protection 666 \200\2237 face velocity, de \201 nition minimum frequency 613 OEL adjustment to business ethics 364 medico-legal work 364 occupational periods of work >8 hours 614 \200\22315 hygienists 598 647 prioritization of sampling substance abuse policies 379 European Inventory of factual witnesses 364 farm workers, prescribed diseases 847 , 848 , 849 , 850 needs 609 sample types 604 structured approach 609 survey types 608 \200\2239 exposure moni toring program design 612 \200\22313 Existing Commercial Chemical Substances (EINECS) 676 farmer \200\231s lung see extrinsic allergic alveolitis 206 , 849 , 872 European List of Noti \201 ed Chemical Substances (ELINCS) 676 femoro-popliteal grafts, expected time off work 409 exposure prevention 634 \200\2235 exposure prone procedures Eustachian tube problems, (EPPs) \201 tness for air travel 483 fertility effects 318 \200\22319 categorization 494 de \201 nition 494 duties of employers 495 duties of healthcare workers 494 evidence-based recovery cadmium 65 carbon disulphide 81 chromium 66 lead 70 methyl ethyl ketone 87 times 408 evidence sources, risk assessment 420 excess (attributable) \201 tness assessment 495 infection transmission to risk 686 excretion 674 expatriate policy 386 \200\2237 FEV 1 760 , 880 \201 bres, airborne patients 494 sampling and analysis 49 50_Smedley_Index.indd 898 1/2/2013 3:36:25 PM INDEX 899 RIDDOR reportable diseases 871 fractures, \201 tness for air passenger travel 483 FRC (fu nctional residual pilots 484 \200\2235 pre-placement see also asbestos \201 bres; machine-made mineral \201 bre (MMMF) assessments 448 \200\2239 psychosocial \201 bromyalgia 461 \200\230 \201 eld blanks \200\231 607 Field Operations factors 450 \200\2231 capacity) 880 safety critical work 504 \200\2235 seafarers 502 \200\2233 work in con \201 ned spaces 500 \201 tness to work with children 498 \200\2239 Freedom of Information Act Directorate 512 2000 582 \200\2233 \201 fth disease 320 \201 lm badges 20 \201 lters, respirators 654 \201 nancial pre ssures, and frequency rate, sickness absence 402 frozen shoulder, diagnostic \200\230 \201 t-notes \200\231 394 \201 xed samples 604 \202 at frequency hearing pro tectors 658 \200\2239 ill-health retirement 413 criteria 257 \201 ngers, osteolysis of Fuller \200\231s earth terminal phalanges 854 Finland, occupational health pneumoconiosis 226 fumes de \201 nition and \202 icker 13 \202 int workers, RIDDOR provision 346 \201 re safety 738 \200\2239 First Aid at Work examples 45 rosin-based solder \202 ux reportable diseases 870 \200\2233 \202 oors, legislation 526 \202 our dust 51 \202 u- like symptoms fume 59